Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.Explore and learn more about Conference Series : World's leading Event Organizer
ConferenceSeries International through its Open Access Initiative is committed to make genuine and reliable contributions to the scientific community. ConferenceSeries hosts over 350 leading-edge peer reviewed Open Access journalsand has organized over 100 scientific conferences all over the world. OMICS Publishing Group journals have over 3 million readers and the fame and success of the same can be attributed to the strong editorial board which contains over 30000 eminent personalities and the rapid, quality and quick review processing. ConferenceSeries Conferences make the perfect platform for global networking as it brings together renowned speakers and scientists across the globe to a most exciting and memorable scientific event filled with much enlightening interactive sessions, world class exhibitions and poster presentations.
Clinical pharmacology is the branch of pharmacology concerned with the pharmacology of therapeutic agents in the prevention, treatment, and control of disease in humans. And it is also defines as the science of drugs and their clinical use. It is underpinned by the basic science of pharmacology, with added focus on the application of pharmacological principles and methods in the real world. It has a broad scope, from the discovery of new target molecules, to the effects of drug usage in whole populations.
Clinical pharmacology connects the gap between medical practice and laboratory science. The main objective is to promote the safety of prescription, maximize the drug effects and minimize the side effects. It is important that there be association with pharmacists skilled in areas of drug information, medication safety and other aspects of pharmacy practice related to Clinical pharmacology
Clinical pharmacology is the scientific discipline that involves all aspects of the relationship between drugs and humans. The term ‘clinical pharmacologist’ is also used in the professional sense to refer to those physicians who are specialists in Clinical pharmacology . They have undertaken several years of postgraduate training in many aspects of the above relationship involving teaching, research and health care. Such clinical pharmacologists have as their primary goal that of improving patient care, directly or indirectly, by developing better medicines and promoting the safer and more effective use of drugs.
Clinical pharmacologists usually have a rigorous medical and scientific training which enables them to evaluate evidence and produce new data through well designed studies. Clinical pharmacologists must have access to enough outpatients for clinical care, teaching and education, and research as well be supervised by medical specialists. Their responsibilities to patients include, but are not limited to analyzing adverse drug effects, therapeutics, and toxicology including reproductive toxicology, cardiovascular risks, preoperative drug management and psychopharmacology.
From critical appraisal of literature, to application of knowledge of drugs, to clinical practice; moving on to clinical and basic research, to drug development process, to policy making - these are but a few of the many fields which constitute the scope of Clinical pharmacology . The importance of the subject lies in allowing a trainee to develop a broad overview of the entire process, from drug generation to drug distribution to drug utilization, a process meant for the greater common goal of better health for all. Clinical pharmacology is a specialty with many attributes and our association with the subject has allowed us to acquire, apply and disseminate myriad aspects of research and practice. Though clinical pharmacologists are conspicuous by virtue of their small number, recent years have shown a growing need for the course. In the review below we navigate through several aspects of the subject as we encountered them from time to time. Iodinated contrast agents have been in use since the 1950s to facilitate radiographic imaging modalities. Physicians in almost all specialties will either administer these agents or care for patients who have received these drugs. Different iodinated contrast agents vary greatly in their properties, uses, and toxic effects. Therefore, clinicians should be at least superficially familiar with the Clinical pharmacology , administration, risks, and adverse effects associated with iodinated contrast agents. This primer offers the non-radiologist physician the opportunity to gain insight into the use of this class of drugs.
OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.
Socities :
• Swiss Society for Clinical Pharmacology and Toxicology
• American Society for Clinical Pharmacology and Therapeutics
• The European Association for Clinical Pharmacology and Therapeutics.
• ACPU (Association Of Clinical Pharmacology Units)
• Canadian Society of Pharmacology and Therapeutics
• Czech Society for Clinical Pharmacology
• SIF - Italian Society of Pharmacology
• Arab Society of Clinical Pharmacology (ASCP)
• The Hungarian Society for Experimental and Clinical Pharmacology
• Hong Kong Pharmacology Society
Companies:
• Novartis
• Abbot Laboratories/AbbVie
• Sanofi
• Medipolis
• Aurobindo Pharma
• Incepta Pharmaceuticals.
• Pfizer
• Johnson & Johnson
• Merck
• GlaxoSmithKline
This page will be updated regularly.
This page was last updated on November 21, 2024
